Your English writing platform
Discover LudwigExact(2)
This trial reveals the benefit of developing risk and hazard based approaches in defining end-point bioremediation of heavy hydrocarbons when engineered biopile or windrow are proposed as treatment option.
If this trial reveals a positive effect of either or both agents, the routine use of these can be recommended in clinical practice and lead to improvement in AVF survival by reducing the rate of early thrombosis, shortening time to dialysis access use, and decreasing the need for additional surgery.
Similar(55)
Preliminary data from this trial reveal that GCV-resistant variants emerge during therapy.
This trial revealed that dulaglutide provided greater glycemic control overall than exenatide twice daily and placebo.
Results from this trial revealed that exenatide LAR improved glycemic control significantly more than twice-daily exenatide.
This trial revealed a safety and tolerability profile that was very similar to that observed in other clinical trials with DPP-4 inhibitors.
Application of this model to data from the placebo arm of this trial revealed important insight into the natural history of skeletal morbidity in patients with bone metastases.
This trial revealed that if patients with post-intubation tracheal stenosis are selected correctly, laser therapy could be used as a beneficial and safe method with satisfactory results.
Results from this trial revealed that liraglutide provided a significantly greater reduction in mean A1C compared with exenatide (−1.12 vs. −0.79%; P < 0.0001) (Supplementary Fig. 2).
A t test conducted on the path lengths for this trial revealed that the hippocampal group (= 591.20 cm, SEM = 150.39 cm) took significantly longer paths to find the platform than the shams (= 212.95 cm, SEM = 15.03 cm), t(20) = 2.75.
A post hoc analysis of the data from this trial revealed that the patients who had the most reduction in pain severity (≥25 mm on the 0 to 100 mm visual analog scale) from baseline had significantly greater improvement in health-related quality of life than those with less reduction in pain.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com